← Open Payments lookup

WENDY DAVIS: Open Payments

NPI 1265005110 · RED BLUFF, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,777 in 140 payments from 21 companies in 2025. Trend: 2023 $2,434 · 2024 $2,938 · 2025 $2,777

Food & beverage: $2,777
CompanyPaymentsAmount
ABBVIE INC.58$1,116
Corcept Therapeutics7$227
Daiichi Sankyo Inc.16$192
Novo Nordisk Inc9$167
Boehringer Ingelheim Pharmaceuticals, Inc.4$160
Vanda Pharmaceuticals Inc.15$152
Astellas Pharma US Inc4$115
Tandem Diabetes Care, Inc.3$114
GlaxoSmithKline, LLC.4$75
PFIZER INC.3$74

Products named: UBRELVY, VRAYLAR, MAVYRET, Korlym, INJECTAFER, QULIPTA, JARDIANCE, FANAPT.

Industry payments across CA — which companies pay providers there.